Bratton Capital Management, L.P. Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001723787

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltBuy & Hold how tags are computed

Q2 2026 · 1 positions · Total reported value $40.81M · Top-10 concentration 100.0% · Updated 2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

Turnover: 0.0% · 0 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

In its Q2 2026 13F filing, Bratton Capital Management, L.P. disclosed 1 equity positions with a combined reported value of $40.81M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / Buy & Hold.

The largest disclosed positions as of Q2 2026 were AQST ($40.81M). By sector, the heaviest allocations are Health Care 100.0%.

Versus the prior quarter, Bratton Capital Management, L.P. opened 0 new positions, trimmed 0 and fully exited 0, a turnover rate of 0.0% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Bratton Capital Management, L.P. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Bratton Capital Management, L.P. files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 1 positions worth $40.81M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 1 positions · $40.81M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: AQST (AQUESTIVE THERAPEUTICS INC COM) at 100.0%
  • Average position size: $40.81M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

AI Rebalance Analysis

1. Overall Direction and Market View: The fund appears to maintain a conservative stance with a focus on stability and growth in the health care sector. The hold position in Aquestive Therapeutics suggests a belief in the company's potential without a significant shift in strategy. 2. Key Moves: There were no additions or reductions in positions this quarter, as indicated by "New: 0." The total value of the portfolio remains at $40.8M, indicating no significant rebalancing in terms of overall asset allocation. 3. Portfolio Structure: The portfolio seems to be passively managed, with a clear sector bias towards health care. The risk appetite is moderate, given the continued hold position in Aquestive Therapeutics, which suggests a preference for companies with established track records rather than high-risk, speculative investments. 4. Per-Holding One-Liner: - AQST (Aquestive Therapeutics Inc.): Aquestive Therapeutics is a biopharmaceutical company focusing on the development and commercialization of therapies for rare and orphan diseases. 'unverified' 5. One-Sentence Style Summary: Bratton Capital Management maintained a stable, passive investment approach in the health care sector this quarter, reiterating confidence in Aquestive Therapeutics without altering the portfolio's composition.

Generated by GLM-4.5-flash from the latest 13F holdings and quarter-over-quarter changes. For reference only, not investment advice.

Sector Allocation

Health Care 100.0%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 9.81M $40.81M 100.00%
100.00%
Hold

FAQ

What did Bratton Capital Management, L.P. buy in 2026-Q2?

In its 2026-Q2 13F filing, Bratton Capital Management, L.P. reported 1 equity positions worth $40.81M in aggregate; its largest disclosed positions were AQST ($40.81M).

How large is Bratton Capital Management, L.P.'s portfolio?

Bratton Capital Management, L.P. reported $40.81M of long equity holdings across 1 positions as of 2026-Q2. Top-10 holdings account for 100.0% of reported value.

What is Bratton Capital Management, L.P.'s investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / Buy & Hold, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/bratton-capital-management/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →